Xeris Pharmaceuticals

Developer of liquid-stable injectables for the delivery of drugs

placeChicago, Illinois, United States calendar_todayFounded 2005 groups294 employees language xerispharma.com

Registered entities

Innovation

29 patent families (20 granted) — focus: Human necessities; filing pace steady. Cited 4,928 times.

YearFilings
20159
20168
201710
20188
201911
202010
20218
20226
20239
202410
20256
20263

Social engagement

Social engagement: 35K social following, 10 posts in the last 12 months — below the industry typical range.

Investor mix

20 investors on record; lead investors include Redmile Group, Central Texas Angel Network, Austin Technology Incubator, Merieux Equity Partners; 1 has since exited.

Investor typeCountShare
Venture capital420%
Private equity210%
Angel & family office210%
Accelerator & incubator15%
Bank & private debt210%
Other / undisclosed945%

Hiring activity

Hires periodically

24 roles tracked across 5 of the last 12 months

4 Feb 2026 · Product Development (Analytical) Intern · Chicago

3 Feb 2026 · Medical Writer · Chicago

2 Feb 2026 · Clinical Project Manager · Chicago

12 Jan 2026 · Pharmaceutical Sales Representative, Endocrinology (Rare Disease) - Phoenix North · Phoenix

12 Jan 2026 · Pharmaceutical Sales Representative, Endocrinology (Rare Disease) - Salt Lake City · Salt Lake City

Based on job postings tracked across public sources.

Recent activity

11 Jun 2026
Event
ENDO 2026
10 Jun 2026
Recognition
regulatory
5 Jun 2026
Event
American Diabetes Association 2026 Scientific Sessions (ADASciSessions)
Coming soon